On February 6, 2020, Crowe BGK held a charity event “Stand Up to Cancer. Sit Down to Brunch” that raised funds for two organizations. Through this fundraiser, the Institut du cancer de Montréal received a total of $82,500.

These funds are necessary to discover and develop new treatments for melanoma. In 2020, it is estimated that 8,000 Canadians will be diagnosed with melanoma.1 In addition, melanoma accounts for approximately 3.8% of new cancer cases.2

In order to give these funds, a call for projects was launched to identify melanoma research projects. An evaluation committee was formed of four researchers from the Institut du cancer de Montréal, who do not have projects in melanoma, and of an external researcher specialized in melanoma. The main evaluation criteria identified were scientific merit, relevance to melanoma, feasibility and impact.

The Institute is therefore proud to announce the two grants recipients:

  • Dr. Francis Rodier’s project – Harnessing Therapy-Induced Senescence to enhance T-cells antitumor response in Melanoma. Awarded $25,000.
  • Dr. Rahima Jamal’s project – Contourner la résistance primaire à l’immunothérapie chez les patients avec mélanome uvéal par la greffe fécale. Awarded $57,500.

Congratulations to the researchers and their team!

Several interesting and relevant projects were submitted demonstrating the many avenues explored on the subject and the importance of the research. If you wish to make a donation dedicated to melanoma research projects, please fill out the donation form and mention “melanoma” in the text box.

 

1 Source: Canadian Cancer Society (2021). Melanoma skin cancer statistics. https://cancer.ca/en/cancer-information/cancer-types/skin-melanoma/statistics
2 Source: Government of Canada (2019). Melanoma Skin Cancer. https://www.canada.ca/en/public-health/services/chronic-diseases/cancer/melanoma-skin-cancer.html